Objectives:

1. Better understanding of the relationship between levodopa pharmacokinetics and pharmacodynamics;
2. Rational therapeutics of parkinson disease using dopaminergic and non-dopaminergic treatments; and
3. Understanding of new levodopa formulations that can help in the management of motor fl uctuations.

Session date: 
Thursday, November 15, 2018 - 7:30am to 8:30am
Speaker Name: 
Peter LeWitt MD
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.